Ingevity Corporation filings document formal disclosure for its specialty materials business, public-company governance, and capital structure. Form 8-K reports cover operating results, segment reporting presentation, credit agreement amendments, material agreements, and completed dispositions of North Charleston crude tall oil refinery assets and the majority of the Industrial Specialties product line.
Proxy and annual-meeting filings disclose director elections, board structure, executive compensation matters, shareholder voting results, and amendments to the company’s equity incentive plan. The filing record also includes disclosures tied to financing arrangements, continuing-operations measures, and governance matters affecting Ingevity’s common stock as a NYSE-listed issuer.
Ingevity Corporation reported second‑quarter 2026 net sales of $314.1 million and net income from continuing operations of $39.8 million, compared with a loss a year earlier that had included a large goodwill impairment. Including discontinued operations, net income was $35.3 million for the quarter and $95.1 million year‑to‑date.
Results reflect portfolio changes and significant special items. The company completed the all‑cash sale of its industrial specialties product line, classified as discontinued operations, recognizing a $54.2 million gain, and sold its road markings product line for $63.2 million, recording an $8.6 million gain in continuing operations. In the Advanced Polymer Technologies segment, a sale process triggered a fair‑value review and a $32.1 million non‑cash long‑lived asset impairment. Segment EBITDA for the quarter totaled $122.7 million, led by Performance Materials at $86.1 million.
Operating activities used $15.8 million of cash in the first half, largely due to a $113.2 million litigation settlement payment to BASF related to prior antitrust counterclaims. Investing activities provided $181.7 million, mainly from divestiture and restricted investment proceeds. Total debt including finance leases was $1,202.8 million, with net leverage of 2.5 and interest coverage of 6.8 under credit‑agreement definitions. The company repurchased 1,265,189 shares for $87.4 million under its $500.0 million authorization.
Ingevity Corporation reported strong second quarter 2026 results. Net sales from continuing operations were $314.1 million, down 5% mainly due to the Road Markings divestiture; excluding that product line, sales increased 5%. Net income from continuing operations was $39.8 million, or $1.13 diluted EPS, compared with a loss of $(141.4) million, or $(3.87) per diluted share, a year earlier. Adjusted EBITDA from continuing operations rose to $115.0 million, with margin expanding to 36.6% from 30.5%.
Performance Materials sales increased 4% to $160.6 million, with segment EBITDA of $86.1 million and a 53.6% margin. Pavement Technologies sales declined to $104.2 million due to the Road Markings sale, but excluding that divestiture grew 3%, with EBITDA of $25.4 million and a 24.4% margin. Advanced Polymer Technologies sales grew 14% to $49.3 million, and segment EBITDA improved to $11.2 million, lifting margin to 22.7%.
Operating cash flow was a negative $15.8 million, driven by a $113.2 million litigation settlement payment; excluding this, free cash flow was $89.1 million. The company repurchased about $35 million of shares and ended the quarter with a Net Debt Ratio of 2.5x. Ingevity raised its 2026 outlook to net sales of $1.05–$1.15 billion, adjusted EBITDA of $380–$400 million, diluted adjusted EPS of $5.00–$5.45, and free cash flow of $220–$245 million (excluding the litigation settlement).
Ingevity Corp reports that SVP and Chief Financial Officer Phillip John Platt had 3,294 shares of common stock withheld by the company on July 24, 2026 at $73.26 per share to satisfy tax withholding obligations on vested restricted stock units, leaving 28,339 shares held directly.
Ingevity Corp senior vice president and general counsel Ryan C. Fisher reported a routine tax-related share disposition. The company withheld 168 shares of common stock at $73.86 per share to satisfy tax obligations on 2024 RSUs that vested.
After this withholding, Fisher directly holds 18,431 shares of Ingevity common stock, indicating the transaction is small relative to his overall position.
Ingevity Corp director Kevin J. Willis reported an award of 397 shares of common stock-equivalent deferred stock units, valued using a reference price of $72.58 per share. Following this grant, his directly owned and deferred stock unit-equivalent holdings total 11,478 shares.
These units represent vested deferred stock units received in lieu of quarterly director fees. Under Ingevity’s Amended and Restated Non-Employee Director Deferred Compensation Plan and 2025 Omnibus Incentive Plan, the units will convert into an equal number of common shares when his board service ends.
Ingevity Corp director Francis David Segal reported an acquisition of 328 shares of Common Stock, recorded as a grant or award valued at $72.58 per share. Following this award, his direct holdings increased to 8,612 shares.
According to the footnote, the 328 vested deferred stock units were granted under Segal’s election to receive DSUs instead of quarterly director fees. These DSUs will convert into an equal number of Ingevity common shares when his board service ends, under the company’s deferred compensation and 2025 omnibus incentive plans.
Cotterman Ryan Joseph reported acquisition or exercise transactions in this Form 4 filing.
Ingevity Corp reported that VP and Chief Accounting Officer Ryan Joseph Cotterman received an equity grant of 2,063 shares of common stock as a compensation award. The grant represents restricted stock units under the Ingevity Corporation 2025 Omnibus Incentive Plan, issued at no cash cost to him.
These restricted stock units will vest in three equal installments on June 22, 2027, 2028, and 2029, tying part of his compensation to future service and company performance. Following this award, Cotterman directly holds 2,063 shares linked to this grant.
Ingevity Corp executive Ryan Joseph Cotterman, who serves as VP and Chief Accounting Officer, has filed a Form 3 insider ownership report. The filing lists him as an officer of the company and does not report any share purchase, sale, or other insider transactions in this excerpt.
Ingevity Corporation appointed Ryan Cotterman, age 44, as Vice President, Chief Accounting Officer and principal accounting officer effective June 22, 2026. He brings prior senior accounting leadership experience from Ralliant Corporation, Cornerstone Building Brands, Advance Auto Parts, and 14 years at Ernst & Young.
His initial annual base salary will be $345,000 with an annual bonus target of 40% of base salary and a long-term incentive opportunity equal to 65% of base salary beginning in 2027. Cotterman will receive a one-time sign-on cash bonus of $40,000 and restricted stock units with a grant date target value of $150,000, vesting over three years.
The company states there are no selection arrangements, family relationships, or related-party transactions requiring disclosure in connection with this appointment.
Ingevity Corp senior vice president and Chief HR Officer Terrance M. Dyer reported open-market sales of company common stock. On May 28, 2026, he sold a total of 496 shares of Ingevity common stock in three transactions at prices between $68.45 and $68.57 per share.